Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2025-12-25 @ 5:09 AM
NCT ID:
NCT01090427
Eligibility Criteria:
Inclusion Criteria:
* Have a diagnosis of plaque-type psoriasis with or without psoriatic arthritis (PsA) for at least 6 months
* Are candidates for phototherapy or systemic treatment of psoriasis
* Have screening laboratory test results within the study parameters
Exclusion Criteria:
* Currently have nonplaque forms of psoriasis
* Have used any therapeutic agent targeted at reducing interleukin-12 (IL-12) or interleukin-23 (IL-23), including but not limited to ustekinumab and briakinumab
* Received conventional systemic therapies or phototherapy within the last 4 weeks
* Received biologic therapies within the last 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
18 Years
Study:
NCT01090427
Study Brief:
Protocol Section:
NCT01090427